BEVERLY, MA--(Marketwired - February 10, 2016) - Cellceutix Corporation (CTIX) (the "Company"), a clinical stage biopharmaceutical ... including the amount and timing of the sale of shares of common stock to Aspire Capital; the fact …
Stock-based compensation expense was $0.3 million for the ... Headquartered in Beverly, Massachusetts, Cellceutix is a publicly-traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing …
Two tid-bits kept Cellceutix Corp (OTCMKTS:CTIX) in the conversation as its Kevetrin drug candidate ... enrolment for a Phase 2 psoriasis drug trial ahead of schedule. The stock rose as much as 10% too. Solar3D (NASDAQ: SLTD) …
CTIX) FREDDIE MAC PFD Z (OTCBB:FMCKJ) gained 0.60%, trading on 439,333 shares to end the trade at $5.00. If we …
More stocks rose than fell. On the New York Stock Exchange, rising shares topped falling ones 1,664 to 1,454 as 832 million shares traded. Nasdaq winners beat losers 2,008 to 1,658 as 1.1 billion shares changed hands. In other …
Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, announced that data from its lead, first-in-class glutaminase inhibitor CB-839 was presented today …
May 10, 2017 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage ... $5.6 …
That move, in turn, sent a shudder through Wall Street, and the stock prices of on-line travel sellers tumbled. At market close, Travelocity's stock had lost 32.6% of its value, and Expedia's share price was down 17.2% (for a rundown of …
BEVERLY, MA--(Marketwired - September 13, 2016) - Cellceutix Corporation (CTIX) ("the Company"), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, antibiotic, and anti …